Market News
Latest news from Stock markets.
Ackman's Pershing Square Inc. to Sell Up to 33.12 Million Shares in IPO
Investor Bill Ackman's Pershing Square Inc. plans to offer up to 33.12 million shares in its initial public offering, at an expected price of $50 per share.
...keep reeding on wsj.com
With jaw-dropping $1 trillion valuation, Anthropic overtakes OpenAI in market cap race
Desperate buyers scooping up a dwindling supply of Anthropic shares have vaulted the AI giant's valuation on some trading platforms to $1 trillion – eclipsing OpenAI's market capitalization in a sea change in the AI race.
...keep reeding on nypost.com
Intel Q1: The Market Has Lost Its Mind
Intel Corporation delivered much stronger than expected Q1 results, driving a near 20% share price surge and continuing its turnaround momentum. INTC's Data Center and AI unit posted over 20% revenue growth and doubled margins, but foundry services remain a significant drag with deep losses. Despite improved performance and guidance, INTC's valuation now appears fully priced for recovery, limiting upside and increasing downside risk.
...keep reeding on seekingalpha.com
Unum: Careful About Investing In Insurance Right Now
Unum Group is rated Hold with a $52/share price target due to limited upside at current valuation. UNM's 9-10x P/E and 2.38% yield offer little premium over risk-free rates, requiring substantial growth or premiumization to justify higher multiples. Persistent LTC block risks, high disability claim incidence, and diversification into lower-margin lines constrain valuation expansion.
...keep reeding on seekingalpha.com
Agomab Reports Full Year 2025 Financial Results and Confirms 2026 Outlook
-- Cash and Cash Investments at December 31, 2025 of €116.5 Million and Gross Proceeds of $208 Million from Initial Public Offering (IPO) Expected to Extend Cash Runway into First Half of 2029 -- -- Positive Interactions with U.S. Food and Drug Administration (FDA) on Design of Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease (FSCD) -- -- On Track to Initiate Phase 2b Study in FSCD with Ontunisertib and Phase 2 Study in Idiopathic Pulmonary Fibrosis (IPF) with AGMB-447 in Second Half of 2026 -- -- Topline Data from Open-Label Long-term Extension Study (OLE) Part of STENOVA Study with Ontunisertib in FSCD and from Phase 1b IPF Study Cohort with AGMB-447 Expected in Second Half of 2026 -- Antwerp, Belgium, April 23, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today reported financial results for the full year period ended December 31, 2025, and confirmed its outlook for 2026. “2025 was a pivotal year for Agomab, with significant progress across our clinical programs and the positive topline results of the STENOVA Phase 2a study with ontunisertib in FSCD.
...keep reeding on globenewswire.com
Stewart Information Services Corporation (STC) Q1 2026 Earnings Call Transcript
Stewart Information Services Corporation (STC) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Helen of Troy Limited (HELE) Q4 2026 Earnings Call Transcript
Helen of Troy Limited (HELE) Q4 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
South Atlantic Bancshares, Inc. (SABK) Beats Q1 Earnings Estimates
South Atlantic Bancshares, Inc. (SABK) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.43 per share a year ago.
...keep reeding on zacks.com
Shore Bancshares (SHBI) Q1 Earnings and Revenues Beat Estimates
Shore Bancshares (SHBI) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.45 per share a year ago.
...keep reeding on zacks.com
SkyWest (SKYW) Tops Q1 Earnings and Revenue Estimates
SkyWest (SKYW) came out with quarterly earnings of $2.21 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $2.42 per share a year ago.
...keep reeding on zacks.com
Princeton Bancorp (BPRN) Beats Q1 Earnings and Revenue Estimates
Princeton Bancorp (BPRN) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.77 per share a year ago.
...keep reeding on zacks.com
PRM Investors Have Opportunity to Join Perimeter Solutions, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Perimeter Solutions, Inc. (“Perimete” or “the Company”) (NYSE: PRM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
...keep reeding on globenewswire.com
Keurig Dr Pepper: A Beverage Portfolio Worthy Of Entry (Rating Upgrade)
Keurig Dr Pepper reported good overall Q1 results. The company's refreshment beverage portfolio remains strong. Coffee results were still weak in Q1, but moderation in coffee prices aids the forward outlook. KDP's acquisition of JDE Peet's bolsters the company's position in the market. KDP stock is undervalued compared to peers, and a DCF valuation estimates the stock to have 46% upside to $41.5.
...keep reeding on seekingalpha.com
Kuehn Law Encourages Investors of Marqeta, Inc. to Contact Law Firm
NEW YORK, April 23, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Marqeta, Inc. (NASDAQ: MQ) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Marqeta caused the company to misrepresent or fail to disclose that: (1) Marqeta understated the regulatory challenges affecting its business outlook; (2) as a result, Marqeta would have to cut its guidance for the fourth quarter of 2024; and (3) as a result, public statements were materially false and/or misleading at relevant times.
...keep reeding on prnewswire.com
Kuehn Law Encourages Investors of Marqeta, Inc. to Contact Law Firm
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Marqeta, Inc. (NASDAQ: MQ) breached their fiduciary duties to shareholders.
...keep reeding on globenewswire.com
SNOWFLAKE INC. DEADLINE: ROSEN, LEADING GLOBAL COUNSEL, Encourages Snowflake Inc. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action - SNOW
New York, New York--(Newsfile Corp. - April 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Snowflake Inc. (NYSE: SNOW) between June 27, 2023 and February 28, 2024, inclusive, (the "Class Period"), of the important April 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Snowflake Inc. securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
Anthropic says Claude Code did get worse — but shoots down speculation it 'nerfed' the model
Anthropic found issues with Claude Code after complaints that the popular tool had gotten worse. The company denied "nerfing" or intentionally degrading the model.
...keep reeding on businessinsider.com
StoneCo Files Its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
George Town, Grand Cayman--(Newsfile Corp. - April 23, 2026) - StoneCo Ltd. (NASDAQ: STNE) ("Stone" or "the Company") hereby informs its shareholders and the market that has filed today, April 23, its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC").
...keep reeding on newsfilecorp.com
Vitrolife AB (publ) (VTRLY) Q1 2026 Earnings Call Transcript
Vitrolife AB (publ) (VTRLY) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Univest Financial Corporation (UVSP) Q1 2026 Earnings Call Transcript
Univest Financial Corporation (UVSP) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Intel's stock soars as results top estimates, with chipmaker showing signs of growth
Intel reported first-quarter earnings Thursday that blew past Wall Street's expectations, as the struggling chipmaker shows signs of a revival. Kristina Partsinevelos has the details.
...keep reeding on youtube.com
Brazil to start tests for diesel blend containing 20% biofuel in May
Brazilian researchers at the Maua Institute of Technology will begin tests to investigate the viability of raising the blend of biodiesel in diesel to 20% in May, Renato Romio, manager of the institute's vehicles division, said on Thursday.
...keep reeding on reuters.com
Stock Market Falls From Record Highs, But These 3 AI Leaders Hit New Buy Points
The stock market dropped from record highs Thursday, but these three AI stock leaders broke out past new buy points.
...keep reeding on investors.com
Ca$htag$: RDDT "Human" Edge Helps Stock Stand Out
Reddit (RDDT) differentiates itself in the social media space, according to Megan Brantley of @LikeFolio. She calls the company a "hybrid" platform that ties social media technology with search capabilities and believes investors are undervaluing the stock.
...keep reeding on youtube.com
Historic Artworks Receive Funding through BofA's Art Conservation Project™
Spanning 10 countries, the 2026 selections highlight the program's global commitment to art conservation Key Points Bank of America is awarding 18 Art Conservation Project™ grants to preserve significant artworks in 2026. This year's projects include the conservation of internationally renowned masterpieces, such as Rembrandt's The Night Watch, Picasso's The Old Guitarist, Matisse's La Négresse, and Titian's Bacchus and Ariadne.
...keep reeding on prnewswire.com
ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages ODDITY Tech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ODD
New York, New York--(Newsfile Corp. - April 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ODDITY Tech Ltd. (NASDAQ: ODD) between February 26, 2025 and February 24, 2026, inclusive, (the "Class Period"), of the important May 11, 2026 lead plaintiff deadline.
...keep reeding on newsfilecorp.com
Kane Biotech Announces Fourth Quarter and Full Year 2025 Financial Results
WINNIPEG, Manitoba, April 23, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane Biotech”) announces today its fourth quarter and full year 2025 financial results.
...keep reeding on globenewswire.com
UPST SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Upstart Holdings, Inc. Investors - Contact Kirby McInerney LLP by June 8, 2026
NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Upstart Holdings, Inc. (“Upstart” or the “Company”) (NASDAQ:UPST) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
...keep reeding on globenewswire.com
SPORTRADAR GROUP AG INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Sportradar Group AG (“Sportradar” or the “Company”) (NASDAQ:SRAD). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 22, 2026, Muddy Waters Research published a report alleging, among other things, that Sp.
...keep reeding on businesswire.com
Fire brought under control at Russia's Tuapse oil terminal
Firefighters have brought under control a blaze that broke out at Russia's Black Sea Tuapse oil refinery after a Ukrainian drone attack, local officials said on Thursday.
...keep reeding on reuters.com
Exclusive: SpaceX warns that inquiries into sexually abusive AI imagery may hurt market access
The multiple investigations into xAI's creation and dissemination of sexually abusive imagery may lead the company to lose access to certain markets, parent company SpaceX warned in a prospectus reviewed by Reuters.
...keep reeding on reuters.com
RTX Corporation: Patience Will Be Rewarded
RTX Corporation is initiated at a buy rating, driven by robust defense demand and a growing backlog. Geopolitical instability and surging Tomahawk orders are fueling long-term tailwinds, though near-term growth is limited by production capacity constraints. Q1 sales rose 9% YoY, with adjusted EPS up 21%; backlog outpaces revenue, signaling sustained demand.
...keep reeding on seekingalpha.com
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the first quarter of 2026 on Thursday, May 7, 2026. Management will hold a conference call beginning at 4:30 pm Eastern time to review the results, provide a business update and answer questions. Participants are encour.
...keep reeding on businesswire.com
INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit- Hagens Berman
SAN FRANCISCO , April 23, 2026 /PRNewswire/ -- ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio securities between January 19, 2026 and March 24, 2026. The lawsuit follows news that the FDA sent a warning letter to the company concerning claims made by its executive chairman and Chief Scientific and Medical Officer (Dr. Patrick Soon-Shiong) regarding ImmunityBio's lead biologic product (Anktiva), which the FDA said were misleading efficacy claims.
...keep reeding on prnewswire.com
Key Tronic Corporation Announces Third Quarter Reporting Date
SPOKANE VALLEY, Wash., April 23, 2026 (GLOBE NEWSWIRE) -- Key Tronic Corporation (Nasdaq: KTCC), announced today that it plans to report its results for the third quarter of fiscal 2026 after market close on May 5, 2026.
...keep reeding on globenewswire.com
Securities Fraud Investigation Into Calix, Inc. (CALX) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Calix, Inc. (“Calix” or the “Company”) (NYSE: CALX) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CALIX, INC. (CALX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On April 21, 2026, Calix reported results for the first quarter of 2026 earnings, inc.
...keep reeding on businesswire.com
Edwards Lifesciences beats quarterly estimates on robust demand for artificial heart valves
Edwards Lifesciences beat Wall Street first-quarter estimates on Thursday, driven by robust demand for its artificial valves used in complex cardiac procedures, sending its shares up over 4% in extended trading.
...keep reeding on reuters.com
First Merchants Corporation (FRME) Q1 2026 Earnings Call Transcript
First Merchants Corporation (FRME) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Liberty Energy Inc. (LBRT) Q1 2026 Earnings Call Transcript
Liberty Energy Inc. (LBRT) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
SOLENO DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Soleno Therapeutics, Inc. Investors With Losses in Excess of $100k to Secure Counsel Before Important Deadline in Securities Class Action- SLNO
New York, New York--(Newsfile Corp. - April 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Soleno Therapeutics, Inc. (NASDAQ: SLNO) between March 26, 2025 and November 4, 2025, inclusive, (the "Class Period"), of the important May 5, 2026 lead plaintiff deadline. SO WHAT: If you purchased Soleno securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
...keep reeding on newsfilecorp.com
Hagens Berman Updates Driven Brands (DRVN) Investors: New Nasdaq Non-Compliance Notice and Internal Review Delays Amid Securities Class Action
SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Hagens Berman, a global shareholder rights law firm, today issues an update to investors in Driven Brands Holdings Inc. (NASDAQ: DRVN) following the company's April 21 admission that it is unable to file its required financial reports and has received a notice of non-compliance from Nasdaq. The disclosures are pertinent to legal claims asserted in a securities class action against Driven Brands alleging violated the federal securities laws.
...keep reeding on prnewswire.com
Mystery solved: Anthropic reveals changes to Claude's harnesses and operating instructions likely caused degradation
For several weeks, a growing chorus of developers and AI power users claimed that Anthropic's flagship models were losing their edge. Users across GitHub, X, and Reddit reported a phenomenon they described as "AI shrinkflation"—a perceived degradation where Claude seemed less capable of sustained reasoning, more prone to hallucinations, and increasingly wasteful with tokens.
...keep reeding on venturebeat.com
INVESTOR DEADLINE: Eos Energy (EOSE) Investors with Substantial Losses Have Opportunity to Lead the Eos Class Action Lawsuit- Hagens Berman
SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- A securities class action lawsuit has been filed against Eos Energy Enterprises (NASDAQ: EOSE), seeking to represent investors who purchased Eos securities between November 5, 2025 and February 26, 2026. The lawsuit follows the 39% decline in the price of Eos shares on Feb. 26, 2026, which wiped out hundreds of millions of dollars of the company's market capitalization.
...keep reeding on prnewswire.com
Grabar Law Office Investigates Claims on Behalf of LKQ Corporation (LKQ) Shareholders
Philadelphia, Pennsylvania--(Newsfile Corp. - April 23, 2026) - What is Happening? Grabar Law Office is investigating potential claims on behalf of investors of LKQ Corporation (NASDAQ: LKQ).
...keep reeding on newsfilecorp.com
INVESTOR NOTICE: Soleno Therapeutics (SLNO) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman
SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of the pending securities class action and the upcoming May 5, 2026 lead plaintiff deadline. The firm urges investors who purchased Soleno common stock between March 26, 2025, and November 4, 2025 (the "Class Period"), and suffered significant losses to submit your losses now.
...keep reeding on prnewswire.com
INVESTOR DEADLINE: Apollo Global Management (APO) Investors with Substantial Losses Have Opportunity to Lead the Apollo Class Action Lawsuit- Hagens Berman
SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman notifies investors of the filing of a securities class action against Apollo Global Management, Inc. (NYSE: APO) following a series of investigative reports. The litigation seeks to represent investors who purchased or otherwise acquired Apollo securities between May 10, 2021, and February 21, 2026 (the "Class Period").
...keep reeding on prnewswire.com
S&P Dow Jones Indices Announces Dow Jones Best-in-Class Indices 2026 Review Results
NEW YORK and AMSTERDAM, April 23, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI"), the world's leading index provider, today announced the results of the annual Dow Jones Best-in-Class Indices (DJ BIC) rebalancing and reconstitution. The DJ BIC are float-adjusted market capitalization weighted indices that track equity markets while applying a sustainability best-in-class selection process.
...keep reeding on prnewswire.com
INVESTOR DEADLINE: Navan, Inc. (NAVN) Investors with Substantial Losses Have Opportunity to Lead the Navan Class Action Lawsuit- Hagens Berman
SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman notifies investors in Navan, Inc. (NASDAQ: NAVN) that the deadline to move for Lead Plaintiff in the pending securities class action is April 24, 2026. REPORT YOUR NAVN INVESTMENT LOSSES TO HBSS NOW The lawsuit, McCown v.
...keep reeding on prnewswire.com
ON Semiconductor: Chip Stocks' Parabolic Rise Draws Concerns
ON Semiconductor has surged over 75% since late March, now approaching its $111 all-time high amid a parabolic technical setup. I maintain a "Hold" rating: Valuation is fair on normalized earnings and PEG, but technicals suggest elevated near-term reversal risk. Q1 guidance targets $1.435–$1.535 billion in revenue and $0.56–$0.66 EPS; long-term goals include 10%–12% revenue CAGR and 53% gross margin.
...keep reeding on seekingalpha.com
Jefferies Financial Group Inc. Announces Pricing of $1,100,000,000 5.125% Senior Notes Due 2031
NEW YORK--(BUSINESS WIRE)--Jefferies Financial Group Inc. (NYSE: JEF) (“JFG”, “we” or “our”) today announced the pricing of its public offering of $1.1 billion aggregate principal amount of 5.125% Senior Notes due 2031 (the “Notes”) with an effective yield of 5.304%, maturing April 28, 2031. The offering is expected to settle on April 28, 2026, subject to the satisfaction of customary closing conditions. JFG intends to use the net proceeds of the offering for general corporate purposes. Jefferi.
...keep reeding on businesswire.com